pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
  1. pharmadog
  2. ›drugs
  3. ›Austedo XR
drug
save

deutetrabenazine ER

Marketedupdated 4mo ago
by Teva Neuroscience Inc
Approved
community read0 votes

all catalysts(0)

nothing on the calendar yet

Trials studying deutetrabenazine ER

  • phase3Impact of Deutetrabenazine on Functional Speech and Gait Dynamics in Huntington Diseaseactive not recruitingn=30
  • phase4Real World Effectiveness and Safety of Deutetrabenazine in Adult Chinese Patients With Huntington's Disease (HD) Chorea in Chinacompletedn=50
  • phase4Deutetrabenazine Treatment for Tardive Dyskinesia in Intellectual/Developmental Disabilitiesnot yet recruitingn=25
  • phase2An Open-label Study to Define the Safety, Tolerability and Clinical Activity of Deutetrabenazine (AUstedo) in Adult Study Subjects With DYsToniacompletedn=15

Patent cliff

source: FDA Orange Book
first barrier falls
Apr 3, 2031
~4.6 years out

Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.

patents (252)

  • Jun 10, 2041formulationUS 11311488
  • Jun 10, 2041formulationUS 11311488
  • Jun 10, 2041formulationUS 11311488
  • Jun 10, 2041formulationUS 11311488
  • Jun 10, 2041formulationUS 11311488
  • Jun 10, 2041formulationUS 11311488
  • Jun 10, 2041formulationUS 11311488
  • Jun 10, 2041formulationUS 11311488
  • Sep 15, 2038patentUS 11179386*PED
  • Sep 15, 2038patentUS 11179386*PED
  • Sep 15, 2038patentUS 11179386*PED
  • Sep 15, 2038patentUS 11179386*PED
  • Sep 15, 2038patentUS 11179386*PED
  • Sep 15, 2038patentUS 11179386*PED
  • Sep 15, 2038patentUS 11179386*PED
  • Sep 15, 2038patentUS 11179386*PED
  • Sep 15, 2038patentUS 11179386*PED
  • Sep 15, 2038patentUS 11179386*PED
  • Sep 15, 2038patentUS 11179386*PED
  • Sep 15, 2038patentUS 11813232*PED
  • Sep 15, 2038patentUS 11813232*PED
  • Sep 15, 2038patentUS 11813232*PED
  • Sep 15, 2038patentUS 11813232*PED
  • Sep 15, 2038patentUS 11813232*PED
  • Sep 15, 2038patentUS 11813232*PED
  • Sep 15, 2038patentUS 11813232*PED
  • Sep 15, 2038patentUS 11813232*PED
  • Sep 15, 2038patentUS 11813232*PED
  • Sep 15, 2038patentUS 11813232*PED
  • Sep 15, 2038patentUS 11813232*PED
  • Mar 15, 2038formulationUS 11179386
  • Mar 15, 2038formulationUS 11179386
  • Mar 15, 2038formulationUS 11179386
  • Mar 15, 2038formulationUS 11179386
  • Mar 15, 2038formulationUS 11179386
  • Mar 15, 2038formulationUS 11179386
  • Mar 15, 2038formulationUS 11179386
  • Mar 15, 2038formulationUS 11179386
  • Mar 15, 2038formulationUS 11179386
  • Mar 15, 2038formulationUS 11179386
  • Mar 15, 2038formulationUS 11179386
  • Mar 15, 2038formulationUS 11813232
  • Mar 15, 2038formulationUS 11813232
  • Mar 15, 2038formulationUS 11813232
  • Mar 15, 2038formulationUS 11813232
  • Mar 15, 2038formulationUS 11813232
  • Mar 15, 2038formulationUS 11813232
  • Mar 15, 2038formulationUS 11813232
  • Mar 15, 2038formulationUS 11813232
  • Mar 15, 2038formulationUS 11813232
  • Mar 15, 2038formulationUS 11813232
  • Mar 15, 2038formulationUS 11813232
  • Sep 7, 2036patentUS 10959996*PED
  • Sep 7, 2036patentUS 10959996*PED
  • Sep 7, 2036patentUS 10959996*PED
  • Sep 7, 2036patentUS 10959996*PED
  • Sep 7, 2036patentUS 10959996*PED
  • Sep 7, 2036patentUS 10959996*PED
  • Sep 7, 2036patentUS 10959996*PED
  • Sep 7, 2036patentUS 10959996*PED
  • Sep 7, 2036patentUS 10959996*PED
  • Sep 7, 2036patentUS 10959996*PED
  • Sep 7, 2036patentUS 10959996*PED
  • Sep 7, 2036patentUS 11357772*PED
  • Sep 7, 2036patentUS 11357772*PED
  • Sep 7, 2036patentUS 11357772*PED
  • Sep 7, 2036patentUS 11357772*PED
  • Sep 7, 2036patentUS 11357772*PED
  • Sep 7, 2036patentUS 11357772*PED
  • Sep 7, 2036patentUS 11357772*PED
  • Sep 7, 2036patentUS 11357772*PED
  • Sep 7, 2036patentUS 11357772*PED
  • Sep 7, 2036patentUS 11357772*PED
  • Sep 7, 2036patentUS 11357772*PED
  • Sep 7, 2036patentUS 11446291*PED
  • Sep 7, 2036patentUS 11446291*PED
  • Sep 7, 2036patentUS 11446291*PED
  • Sep 7, 2036patentUS 11446291*PED
  • Sep 7, 2036patentUS 11446291*PED
  • Sep 7, 2036patentUS 11446291*PED
  • Sep 7, 2036patentUS 11446291*PED
  • Sep 7, 2036patentUS 11446291*PED
  • Sep 7, 2036patentUS 11446291*PED
  • Sep 7, 2036patentUS 11446291*PED
  • Sep 7, 2036patentUS 11446291*PED
  • Sep 7, 2036patentUS 11564917*PED
  • Sep 7, 2036patentUS 11564917*PED
  • Sep 7, 2036patentUS 11564917*PED
  • Sep 7, 2036patentUS 11564917*PED
  • Sep 7, 2036patentUS 11564917*PED
  • Sep 7, 2036patentUS 11564917*PED
  • Sep 7, 2036patentUS 11564917*PED
  • Sep 7, 2036patentUS 11564917*PED
  • Sep 7, 2036patentUS 11564917*PED
  • Sep 7, 2036patentUS 11564917*PED
  • Sep 7, 2036patentUS 11564917*PED
  • Sep 7, 2036patentUS 11648244*PED
  • Sep 7, 2036patentUS 11648244*PED
  • Sep 7, 2036patentUS 11648244*PED
  • Sep 7, 2036patentUS 11648244*PED
  • Sep 7, 2036patentUS 11648244*PED
  • Sep 7, 2036patentUS 11648244*PED
  • Sep 7, 2036patentUS 11648244*PED
  • Sep 7, 2036patentUS 11648244*PED
  • Sep 7, 2036patentUS 11648244*PED
  • Sep 7, 2036patentUS 11648244*PED
  • Sep 7, 2036patentUS 11648244*PED
  • Sep 7, 2036patentUS 12016858*PED
  • Sep 7, 2036patentUS 12016858*PED
  • Sep 7, 2036patentUS 12016858*PED
  • Sep 7, 2036patentUS 12016858*PED
  • Sep 7, 2036patentUS 12016858*PED
  • Sep 7, 2036patentUS 12016858*PED
  • Sep 7, 2036patentUS 12016858*PED
  • Sep 7, 2036patentUS 12016858*PED
  • Sep 7, 2036patentUS 12016858*PED
  • Sep 7, 2036patentUS 12016858*PED
  • Sep 7, 2036patentUS 12016858*PED
  • Mar 7, 2036method-of-use (U-3055)US 10959996
  • Mar 7, 2036method-of-use (U-3055)US 10959996
  • Mar 7, 2036method-of-use (U-3055)US 10959996
  • Mar 7, 2036method-of-use (U-3055)US 10959996
  • Mar 7, 2036method-of-use (U-3055)US 10959996
  • Mar 7, 2036method-of-use (U-3055)US 10959996
  • Mar 7, 2036method-of-use (U-3055)US 10959996
  • Mar 7, 2036method-of-use (U-3055)US 10959996
  • Mar 7, 2036method-of-use (U-3055)US 10959996
  • Mar 7, 2036method-of-use (U-3055)US 10959996
  • Mar 7, 2036method-of-use (U-3055)US 10959996
  • Mar 7, 2036method-of-use (U-1995)US 11357772
  • Mar 7, 2036method-of-use (U-3055)US 11357772
  • Mar 7, 2036method-of-use (U-3055)US 11357772
  • Mar 7, 2036method-of-use (U-3055)US 11357772
  • Mar 7, 2036method-of-use (U-3055)US 11357772
  • Mar 7, 2036method-of-use (U-1995)US 11357772
  • Mar 7, 2036method-of-use (U-1995)US 11357772
  • Mar 7, 2036method-of-use (U-1995)US 11357772
  • Mar 7, 2036method-of-use (U-3055)US 11357772
  • Mar 7, 2036method-of-use (U-1995)US 11357772
  • Mar 7, 2036method-of-use (U-3055)US 11357772
  • Mar 7, 2036method-of-use (U-1995)US 11446291
  • Mar 7, 2036method-of-use (U-1995)US 11446291
  • Mar 7, 2036method-of-use (U-1995)US 11446291
  • Mar 7, 2036method-of-use (U-1995)US 11446291
  • Mar 7, 2036method-of-use (U-1995)US 11446291
  • Mar 7, 2036method-of-use (U-1995)US 11446291
  • Mar 7, 2036method-of-use (U-1995)US 11446291
  • Mar 7, 2036method-of-use (U-1995)US 11446291
  • Mar 7, 2036method-of-use (U-1995)US 11446291
  • Mar 7, 2036method-of-use (U-1995)US 11446291
  • Mar 7, 2036method-of-use (U-1995)US 11446291
  • Mar 7, 2036method-of-use (U-1995)US 11564917
  • Mar 7, 2036method-of-use (U-1995)US 11564917
  • Mar 7, 2036method-of-use (U-1995)US 11564917
  • Mar 7, 2036method-of-use (U-1995)US 11564917
  • Mar 7, 2036method-of-use (U-1995)US 11564917
  • Mar 7, 2036method-of-use (U-1995)US 11564917
  • Mar 7, 2036method-of-use (U-1995)US 11564917
  • Mar 7, 2036method-of-use (U-1995)US 11564917
  • Mar 7, 2036method-of-use (U-1995)US 11564917
  • Mar 7, 2036method-of-use (U-1995)US 11564917
  • Mar 7, 2036method-of-use (U-1995)US 11564917
  • Mar 7, 2036method-of-use (U-1995)US 11648244
  • Mar 7, 2036method-of-use (U-1995)US 11648244
  • Mar 7, 2036method-of-use (U-1995)US 11648244
  • Mar 7, 2036method-of-use (U-1995)US 11648244
  • Mar 7, 2036method-of-use (U-1995)US 11648244
  • Mar 7, 2036method-of-use (U-1995)US 11648244
  • Mar 7, 2036method-of-use (U-1995)US 11648244
  • Mar 7, 2036method-of-use (U-1995)US 11648244
  • Mar 7, 2036method-of-use (U-1995)US 11648244
  • Mar 7, 2036method-of-use (U-1995)US 11648244
  • Mar 7, 2036method-of-use (U-1995)US 11648244
  • Mar 7, 2036method-of-use (U-1995)US 12016858
  • Mar 7, 2036method-of-use (U-1995)US 12016858
  • Mar 7, 2036method-of-use (U-1995)US 12016858
  • Mar 7, 2036method-of-use (U-1995)US 12016858
  • Mar 7, 2036method-of-use (U-1995)US 12016858
  • Mar 7, 2036method-of-use (U-1995)US 12016858
  • Mar 7, 2036method-of-use (U-1995)US 12016858
  • Mar 7, 2036method-of-use (U-3055)US 12016858
  • Mar 7, 2036method-of-use (U-3055)US 12016858
  • Mar 7, 2036method-of-use (U-3055)US 12016858
  • Mar 7, 2036method-of-use (U-3055)US 12016858
  • Mar 18, 2034patentUS 11666566*PED
  • Mar 18, 2034patentUS 11666566*PED
  • Mar 18, 2034patentUS 11666566*PED
  • Mar 18, 2034patentUS 9233959*PED
  • Mar 18, 2034patentUS 9233959*PED
  • Mar 18, 2034patentUS 9233959*PED
  • Mar 18, 2034patentUS 9296739*PED
  • Mar 18, 2034patentUS 9296739*PED
  • Mar 18, 2034patentUS 9296739*PED
  • Mar 18, 2034patentUS 9550780*PED
  • Mar 18, 2034patentUS 9550780*PED
  • Mar 18, 2034patentUS 9550780*PED
  • Mar 18, 2034patentUS 9550780*PED
  • Mar 18, 2034patentUS 9550780*PED
  • Mar 18, 2034patentUS 9550780*PED
  • Mar 18, 2034patentUS 9550780*PED
  • Mar 18, 2034patentUS 9550780*PED
  • Mar 18, 2034patentUS 9550780*PED
  • Mar 18, 2034patentUS 9550780*PED
  • Mar 18, 2034patentUS 9550780*PED
  • Mar 18, 2034patentUS 9814708*PED
  • Mar 18, 2034patentUS 9814708*PED
  • Mar 18, 2034patentUS 9814708*PED
  • Sep 18, 2033formulationUS 11666566
  • Sep 18, 2033formulationUS 11666566
  • Sep 18, 2033formulationUS 11666566
  • Sep 18, 2033formulationUS 9233959
  • Sep 18, 2033formulationUS 9233959
  • Sep 18, 2033formulationUS 9233959
  • Sep 18, 2033formulationUS 9296739
  • Sep 18, 2033formulationUS 9296739
  • Sep 18, 2033formulationUS 9296739
  • Sep 18, 2033compositionUS 9550780
  • Sep 18, 2033compositionUS 9550780
  • Sep 18, 2033compositionUS 9550780
  • Sep 18, 2033compositionUS 9550780
  • Sep 18, 2033compositionUS 9550780
  • Sep 18, 2033compositionUS 9550780
  • Sep 18, 2033compositionUS 9550780
  • Sep 18, 2033compositionUS 9550780
  • Sep 18, 2033compositionUS 9550780
  • Sep 18, 2033compositionUS 9550780
  • Sep 18, 2033compositionUS 9550780
  • Sep 18, 2033formulationUS 9814708
  • Sep 18, 2033formulationUS 9814708
  • Sep 18, 2033formulationUS 9814708
  • Oct 3, 2031patentUS 8524733*PED
  • Oct 3, 2031patentUS 8524733*PED
  • Oct 3, 2031patentUS 8524733*PED
  • Oct 3, 2031patentUS 8524733*PED
  • Oct 3, 2031patentUS 8524733*PED
  • Oct 3, 2031patentUS 8524733*PED
  • Oct 3, 2031patentUS 8524733*PED
  • Oct 3, 2031patentUS 8524733*PED
  • Oct 3, 2031patentUS 8524733*PED
  • Oct 3, 2031patentUS 8524733*PED
  • Oct 3, 2031patentUS 8524733*PED
  • Apr 3, 2031compositionUS 85247334.6y
  • Apr 3, 2031compositionUS 85247334.6y
  • Apr 3, 2031compositionUS 85247334.6y
  • Apr 3, 2031compositionUS 85247334.6y
  • Apr 3, 2031compositionUS 85247334.6y
  • Apr 3, 2031compositionUS 85247334.6y
  • Apr 3, 2031compositionUS 85247334.6y
  • Apr 3, 2031compositionUS 85247334.6y
  • Apr 3, 2031compositionUS 85247334.6y
  • Apr 3, 2031compositionUS 85247334.6y
  • Apr 3, 2031compositionUS 85247334.6y

News(0)

no news has mentioned this drug yet

brand
Austedo XR
generic
deutetrabenazine
indication
Chorea
phase
marketed
Data sources
ClinicalTrials.gov
last refreshed 9h ago
Found something off?
🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?